As per MRFR analysis, the US Clinical Laboratory Test Market Size was estimated at 8.3 (USD Billion) in 2023. The US Clinical Laboratory Test Market Industry is expected to grow from 9.56 (USD Billion) in 2024 to 19.3 (USD Billion) by 2035. The US Clinical Laboratory Test Market CAGR (growth rate) is expected to be around 6.6% during the forecast period (2025 - 2035).
Currently, the US Clinical Laboratory Test Market is influenced by a number of significant market drivers. The increasing emphasis on preventive healthcare is a significant factor contributing to the increased demand for routine and diagnostic tests. The necessity for consistent testing to effectively manage health is also driven by the expansion of geriatric populations in the United States and a rise in chronic diseases.
Additionally, the integration of sophisticated technologies, including molecular diagnostics and automation, in laboratories improves the precision and efficiency of testing, which is advantageous to both healthcare providers and patients. The increasing popularity of personalized medication presents an opportunity to investigate opportunities in the United States market.
This method necessitates sophisticated laboratory tests to inform therapy decisions and customizes treatments according to the unique characteristics of each patient. The movement toward value-based healthcare is motivating laboratories to deliver more precise and rapid test results, necessitating that they adjust to innovative methodologies and emergent technologies.
In addition, the expansion of telehealth presents opportunities for remote testing services, which facilitate access to laboratory tests from the comfort of one's home. This is particularly beneficial in underserved populations.
The utilization of point-of-care testing (POCT) has made substantial strides in recent years, providing immediate results in a variety of contexts, including medical offices and clinics. This convenience is designed to meet the requirements of patients who require prompt diagnoses.
Furthermore, the clinical laboratory landscape has been transformed by the increasing emphasis on mental health, which has increased the testing of conditions such as anxiety and depression. It is also important to note the trend of regulatory changes, as the US government is consistently updating guidelines that may affect laboratory operations and testing protocols. This promotes the maintenance of compliance and agility in laboratories.
The United States is experiencing a significant increase in chronic diseases, which is a major driver for the US Clinical Laboratory Test Market Industry. According to the Centers for Disease Control and Prevention (CDC), nearly 6 in 10 adults in the US live with at least one chronic disease, such as diabetes, heart disease, or cancer. This growing patient population necessitates regular laboratory testing for diagnosis and management.
The American Cancer Society reports that over 1.9 million new cancer cases were expected in the US in 2021 alone, which highlights the critical need for clinical laboratory tests to monitor and treat these patients effectively. Established organizations like Quest Diagnostics and LabCorp are significant players in this space, providing an extensive range of laboratory tests that cater to the needs of patients suffering from chronic conditions. As chronic diseases continue to rise, the demand for clinical laboratory services is projected to increase, driving market growth.
Innovation in diagnostic testing technologies is another key factor contributing to the growth of the US Clinical Laboratory Test Market Industry. The introduction of advanced techniques such as Next-Generation Sequencing (NGS) and Liquid Biopsy has transformed the landscape of laboratory diagnostics. The Clinical Laboratory Improvement Amendments (CLIA) permit laboratories in the US to perform a wide variety of tests, which establishes a competitive environment that encourages technological improvements.
Companies like Illumina and Roche are at the forefront of these innovations, offering state-of-the-art solutions that enhance the accuracy and efficiency of laboratory testing. As the healthcare system increasingly adopts these technologies, it is expected to boost the demand for clinical laboratory services significantly.
There has been a significant rise in health awareness among the US population, leading to an increase in preventive healthcare practices. According to the National Center for Health Statistics, about 84% of adults in the US reported having at least one preventive healthcare visit in recent years, driven by efforts to catch diseases early. This trend influences the US Clinical Laboratory Test Market Industry positively as more individuals seek laboratory tests for screening purposes.
Organizations such as the United States Preventive Services Task Force (USPSTF) advocate for regular screenings, including blood tests and cancer screenings, which spur demand for laboratory services. Furthermore, the Affordable Care Act has promoted preventive services, covering many laboratory tests, thereby encouraging more Americans to utilize these essential diagnostic tools.
The Type of Laboratory segment plays a crucial role in shaping the dynamics of the US Clinical Laboratory Test Market, reflecting a diverse landscape that caters to the various healthcare needs of the population. The market is classified into different types of laboratories, each serving distinct functions and patient demographics. Hospital-based laboratories are fundamental as they provide a wide range of diagnostic testing to inpatients and outpatients, facilitating critical decision-making in immediate care settings.
These laboratories often operate with advanced technology and resources, supporting a large volume of tests that are integral for patient management within the hospital environment. In contrast, Central or Independent laboratories are characterized by their ability to handle higher throughput of tests and diverse test menus, often specializing in specific types of diagnostics that may not be available in smaller or hospital-based setups.
This segment supports an array of clinical and research collaborations, thereby enhancing the availability of sophisticated testing solutions that are instrumental in complex cases. Additionally, Physician Office Laboratories (POL) are gaining traction due to their capacity to deliver quick test results, which enhances the patient experience by enabling immediate clinical decisions. They simplify the diagnostic process for both physicians and patients, thus bridging gaps in care delivery.
Each type of laboratory is essential to the overall efficiency of healthcare services, with their varying capabilities catering to different aspects of patient care. The Other laboratories, which include specialty and research-focused entities, contribute unique insights and expertise to the market, driving innovation and laboratory-developed tests. Collectively, these laboratory types address the growing demand for laboratory testing, which is spurred by factors such as the increased prevalence of chronic diseases, advancements in technology, and a stronger push for preventive healthcare measures.
Moreover, evolving regulations and the need for high-quality standards across the laboratory ecosystem present both challenges and opportunities for market growth. Overall, the diversity in the Type of Laboratory segment underscores its significance in advancing diagnostic capabilities within the healthcare infrastructure of the United States.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Clinical Laboratory Test Market, particularly focusing on the Type of Test segmentation, showcases a diverse array of testing methodologies essential for disease diagnosis and management. Among these, CBC and Routine Blood Tests are foundational, often serving as the first line of investigation in clinical evaluations. Anatomic Pathology plays a critical role in cancer diagnosis and disease characterization, contributing significantly to patient treatment plans.
Meanwhile, Molecular Tests are gaining traction as they allow for precise identification of genetic diseases and pathogens, driving advancements in personalized medicine. Immunology Tests are crucial for assessing immune response and helping diagnose conditions like autoimmune disorders and allergies. Drug Tests are increasingly prevalent due to rising concerns over substance abuse and the need for compliance monitoring in various industries.
Other emerging tests complement these traditional approaches, expanding the market's capabilities. The US Clinical Laboratory Test Market data indicates that evolving healthcare needs and technologies are shaping these segments, highlighting opportunities for innovation and growth. Market growth is also supported by increasing health awareness, an aging population, and a rising prevalence of chronic diseases across the United States. These dynamics contribute to a robust industry landscape, making the Type of Test segment vital for healthcare professionals and providers.
The US Clinical Laboratory Test Market is characterized by a diverse range of players that compete vigorously to provide advanced diagnostic solutions. Market competition is shaped by factors such as technological innovation, regulatory compliance, reimbursement policies, and evolving healthcare needs. In recent years, there has been a surge in the demand for personalized medicine and preventive care, which has prompted clinical laboratories to adapt their offerings and expand services.
Strong competition is noted across various segments of the market, including molecular diagnostics, clinical chemistry, immunoassay, and hematology, with each segment undergoing continuous enhancement through research and collaborations. Companies are striving to leverage cutting-edge technologies, such as automation and artificial intelligence, to enhance diagnostic accuracy and operational efficiencies, thereby positioning themselves favorably in this dynamic market.
Exact Sciences stands out in the US Clinical Laboratory Test Market, particularly known for its focus on early cancer detection and prevention. The company has established itself as a pivotal player through its innovative testing methodologies and a strong emphasis on research and development. With a proprietary portfolio that includes non-invasive tests primarily used for colorectal cancer screening, Exact Sciences has garnered a significant market presence.
The company's strengths lie in its commitment to delivering actionable results with high sensitivity and specificity, which resonates well with healthcare providers and patients alike. Furthermore, Exact Sciences has fostered beneficial partnerships with various healthcare institutions, further extending its reach and solidifying its competitive position in the market.
Abbott Laboratories operates within the US Clinical Laboratory Test Market with a comprehensive range of diagnostic products and services, particularly focusing on areas such as infectious diseases, autoimmune disorders, and cardiac health. The company is renowned for its extensive product lineup, which includes test kits and analyzers that are utilized in laboratories and point-of-care settings. Abbott's strengths come from its large-scale research capabilities and a robust supply chain that enables efficient product distribution across the US.
The company has made strategic moves through mergers and acquisitions to bolster its diagnostic portfolio, enhancing its capabilities and market position. In particular, Abbott’s advanced testing technologies, like molecular diagnostics and rapid testing solutions, demonstrate its unwavering commitment to innovation and meeting healthcare demands, allowing it to maintain a strong foothold in the competitive landscape of the clinical laboratory test market.
The US Clinical Laboratory Test Market has witnessed significant developments in recent months. In September 2023, Quest Diagnostics announced the launch of a new genetic testing service aimed at improving the detection of hereditary cancers, highlighting the market's progressive shift towards personalized medicine. Furthermore, in August 2023, Abbott Laboratories reported a 10% growth in its diagnostics division, driven by increased demand for molecular testing and rapid COVID-19 testing solutions. Merger and acquisition activity remains robust, with Thermo Fisher Scientific completing its acquisition of PPD, a prominent contract research organization, in April 2023, which enhances its capabilities in clinical research services.
LabCorp also expanded its portfolio by acquiring a company focused on digital health services in June 2023, aligning with market trends emphasizing technology integration into diagnostics. Additionally, Hologic reported strong financial results in the second quarter of 2023, underscoring market resilience amid ongoing public health initiatives. Over the past few years, investments in laboratory automation and genomic testing have surged, reflecting a broader trend towards enhancing patient outcomes through advanced diagnostics in the competitive US market.
| Report Attribute/Metric | Details |
| Market Size 2023 | 8.3(USD Billion) |
| Market Size 2024 | 9.56(USD Billion) |
| Market Size 2035 | 19.3(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 6.6% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Exact Sciences, Abbott Laboratories, Thermo Fisher Scientific, Cerner, Quest Diagnostics, PerkinElmer, CSL Behring, Hologic, Genomic Health, LabCorp, BioReference Laboratories, McKesson, Roche Diagnostics, Siemens Healthineers, IDEXX Laboratories |
| Segments Covered | Type of Laboratory, Type of Test |
| Key Market Opportunities | Telehealth integration expansion, Point-of-care testing growth, Rising chronic disease prevalence, Personalized medicine advancements, AI-driven diagnostics innovation |
| Key Market Dynamics | technological advancements, increasing prevalence of diseases, demand for personalized medicine, regulatory changes, expansion of telehealth services |
| Countries Covered | US |
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
